Article Information
History
- December 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yasuhiro Ikami, M.D.a,
- Daisuke Izumi, M.D.a,*,
- Shinya Fujiki, M.D.a,
- Hirotaka Sugiura, M.D.b,
- Sou Otsuki, M.D.a,
- Naomasa Suzuki, M.D.a,
- Yuta Sakaguchi, M.D.a,
- Takahiro Hakamata, M.D.a,
- Yuki Hasegawa, M.D.a,
- Nobue Yagihara, M.D.a,
- Kenichi Iijima, M.D.a,
- Takahiro Tanaka, Ph.D.c,
- Masahiro Ishizawa, M.D.c,
- Masaomi Chinushi, M.D.d,
- Tohru Minamino, M.D.a,e and
- Takayuki Inomata, M.D.a
- aDepartment of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8510, Japan
- bDepartment of Cardiovascular Medicine, Niigata Medical Center, Niigata, 950-2022, Japan
- cClinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, 951-8520, Japan
- dSchool of Health Science, Faculty of Medicine, Niigata University, Niigata, 951-8518, Japan
- eDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan
- ↵*Address correspondence to: Daisuke Izumi M.D., Ph.D. E-mail: dizumi{at}med.niigata-u.ac.jp Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences 1-757 Asahimachidori, Chuo-ku, Niigata 951-8510, Japan Phone: +81-25-227-2185, Fax: +81-25-227-0774
Posted December 19, 2023.
Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban - a clinical prospective randomized study
